4.3 Article

Pathology Training for Cancer Diagnosis in Africa Perspectives From Two Virtual Courses

Journal

AMERICAN JOURNAL OF CLINICAL PATHOLOGY
Volume 157, Issue 2, Pages 279-285

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/ajcp/aqab131

Keywords

Pathology; Education; Virtual; Nigeria; Africa; Cancer

Categories

Funding

  1. Merck Co.

Ask authors/readers for more resources

Virtual training in cancer pathology is a promising tool in Africa, as participants are highly satisfied with the virtual format and have seen improvement in their knowledge during the course.
Objectives In response to requests for training in cancer pathology, two virtual training courses were organized: one in English for participants in Nigeria and another in French for participants in Francophone Africa. Each course had weekly 90-minute sessions covering essential topics in cancer pathology led by global experts. Methods Two research questions were investigated for both courses: (1) did the participants improve their knowledge of the topics covered during the course, and (2) did the course participants appreciate the virtual training format? Results The Nigeria course enrolled 85 participants from 26 Nigerian states; the Francophone Africa course enrolled 425 participants from 18 African countries. In the pre-post technical assessment, participants increased their scores on average by 3.4% (P > .05) in the Nigeria course and by 13.1% (P < .001) in the Francophone Africa course. On the postcourse survey, 95.8% of Nigerian respondents and 96.1% of Francophone African respondents reported being satisfied or very satisfied with the virtual format. Conclusions Virtual training is a promising tool to improve cancer diagnosis in Africa, as the experience of the courses illustrates that participants appreciate the virtual format. Continued training is required to reinforce skills and enable participants to appropriately apply new knowledge to their daily practice.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available